20032018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Kun Luo is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Ubiquitin-Protein Ligases Medicine & Life Sciences
HIV-1 Medicine & Life Sciences
Cytidine Deaminase Medicine & Life Sciences
Human immunodeficiency virus 1 Agriculture & Biology
Cullin Proteins Medicine & Life Sciences
Antiviral Agents Medicine & Life Sciences
Virion Medicine & Life Sciences
ubiquitin-protein ligase Agriculture & Biology

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2018

Interferon Type I
Interleukin-10
Dendritic Cells
Melanoma
Vaccines

Extended protection capabilities of an immature dendritic-cell targeting malaria sporozoite vaccine

Luo, K., Zavala, F. P., Gordy, J., Zhang, H. & Markham, R. B., Apr 25 2017, In : Vaccine. 35, 18, p. 2358-2364 7 p.

Research output: Contribution to journalArticle

Chemokine CCL20
Malaria Vaccines
Sporozoites
sporozoites
dendritic cells
gp100 Melanoma Antigen
Chemokines
Dendritic Cells
Melanoma
Vaccines
Single-Domain Antibodies
Integrins
HIV-1
Lymphocyte Function-Associated Antigen-1
Anti-Infective Agents

A first-in-class NAE inhibitor, MLN4924, blocks lentiviral infection in myeloid cells by disrupting neddylation-dependent Vpx-mediated SAMHD1 degradation

Wei, W., Guo, H., Liu, X., Zhang, H., Qian, L., Luo, K., Markham, R. B. & Yua, X. F., Jan 2014, In : Journal of Virology. 88, 1, p. 745-751 7 p.

Research output: Contribution to journalArticle

Simian immunodeficiency virus
ubiquitin-protein ligase
antineoplastic agents
enzyme inhibitors
Enzyme Inhibitors